(Anonymous) Notes of a Paxil guinea pig What does GSK owe to the youngsters in its infamous Study 329 who became suicidal while taking the company’s paroxetine (Paxil/Seroxat)? As someone who was briefly a GSK Guinea Pig, I’d say the most important thing they’re owed is the truth. It’s a highly delinquent debt – but it’s not too late for GSK to pay up. I took part in a … [Read more...] about Lives Touched by GSK
Search Results for: What to do about suicide
The Church of GSKology
Editorial Note: This post is about midway through a series of posts that are broadly part of the AbbVie series. The series began with GSK's Transparency and Access Journey, moved on to The House of GSK and will have at least two more posts after this. Reading the Minneapolis StarTribune, it was the reference to privacy that clinched it. Facing a sexual abuse lawsuit, the … [Read more...] about The Church of GSKology
The House of GSK
In a just published article in the BMJ, Peter Doshi notes how in recent months the English pharmaceutical company GlaxoSmithKline (GSK) have assiduously portrayed themselves as advocates of transparency and in support of access to clinical trial data. Well in support of 'Responsible Access'. Responsible essentially means that a researcher commits to the primacy of RCTs and … [Read more...] about The House of GSK
GSK’s Transparency and Access Journey
Editorial Note: This post has been put together by Peter Goetzsche and David Healy Dear Dr Goetzsche ... "At GSK we firmly believe that making more information available, including clinical study reports and anonymised patient-level data, will enable researchers to study the science behind today’s medicines more closely, to learn more about them and how they can best be … [Read more...] about GSK’s Transparency and Access Journey
Neal Parker Avoiding Adverse Events
Editorial Note: Neal Parker, Section Head Legal, Biologics Strategic Development at AbbVie, was an industry representative on a panel organized by EFPIA - The European Federation of Pharmaceutical Industries and Associates on August 27th in Bruxelles. In two posts AbbVie's Mission to Discover New Diseases and AbbVie's Mission to Discover New Patients, we gave a transcript of … [Read more...] about Neal Parker Avoiding Adverse Events
EU-nuch in the Humira-m
No such thing as being 'European' There is no such thing as being European when you take a drug like Humira or Depakote and something goes wrong. When something goes wrong on their drug, companies go to extraordinary lengths to make it almost impossible for doctors or patients to report adverse events. It’s part of a larger mission to transform what were poisons to be used … [Read more...] about EU-nuch in the Humira-m
Marilyn’s Curse
Editorial Note: This an unexpected eighth part to the Lasagna Trilogy that started with Not So Bad Pharma and runs through to Witty A: Report to the President. Ondine Ondine was a nymph whose lover swore that his every waking breath was a testimony to his love of her. Finding him unfaithful, she cursed him – should he fall asleep he would stop breathing. Marilyn died of an … [Read more...] about Marilyn’s Curse
Witty A: Report to the President
Editorial Note: This was to be the last in the Lasagna posts that began with Not So Bad Pharma, April Fool in Harlow, The Tragedy of Lou Lasagna, Empire of Humbug: Bad Pharma, Empire of Humbug 2, and Brand Fascism. But the series will continue into Marilyn's Curse and When does Yes Mean No. Faced with questions about the $3 Billion fine imposed on GSK – is it just the cost of … [Read more...] about Witty A: Report to the President
Brand Fascism
Editorial Note: This is the sixth in the Lasagna series of posts that began with Not So Bad Pharma, April Fool in Harlow, Tragedy of Lou Lasagna, Empire of Humbug: Bad Pharma and will continue through to Witty A: Report to the President. Faced with questions about the $3 Billion fine imposed on GSK – Is it just the cost of doing business? Andrew Witty, GSK's CEO, snapped … [Read more...] about Brand Fascism
The Empire of Humbug: Not So Bad Pharma
Editorial Note: This is the fifth is the Lasagna series of posts that began with Not So Bad Pharma, April Fool in Harlow, The Tragedy of Lou Lasagna, Empire of Humbug: Bad Pharma and will continue through to Brand Fascism and Witty A: Report to the President. In 1954 soon after his article with Beecher put the placebo on the map, Lasagna was recruited from Harvard to Hopkins. … [Read more...] about The Empire of Humbug: Not So Bad Pharma